ArticleNeuroradiology2026
Perivascular spaces as MRI markers associated with radiation necrosis in brain metastases patients: an exploratory study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeRadiation necrosis (RN) is a significant complication of stereotactic radiotherapy (SRT) for brain metastases. We investigated whether pre-treatment cerebral small vessel disease (cSVD) burden, particularly perivascular spaces (PVSs), is associated with RN risk. MATERIALS AND
methodsThis single-center retrospective study included 71 patients treated with fractionated SRT for brain metastases. RN was diagnosed by consensus using multiparametric MRI including DSC perfusion. Pre-treatment cSVD markers were evaluated according to STRIVE criteria, with PVSs graded using Potter's criteria in the basal ganglia (BG), centrum semiovale (CS), and midbrain (MB). Associations with RN were assessed using Firth's penalized logistic regression adjusted for age and sex.
resultsRN developed in 33 patients (46.5%). Higher PVS grades in the CS were significantly associated with increased RN risk (grade 1: OR 6.35, 95% CI 1.86-21.72, p = 0.003; grade 2: OR 26.26, 95% CI 3.64-189.61, p = 0.001). Associations were also observed for higher PVS burden in the BG and MB, although these rested on small subsets with wide confidence intervals. Other cSVD markers showed no significant associations. Confidence intervals were wide due to sparse data in higher PVS grades.
conclusionsThis exploratory study suggests a potential association between pre-treatment PVS burden and RN risk. However, sparse data, wide confidence intervals, and the absence of lesion-level dosimetric adjustment limit conclusions. These preliminary findings warrant validation in larger, prospective cohorts with comprehensive dosimetric analysis.
Indexed as
Identifiers
42848065What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.